Principia Biopharma Inc (PRNB) Stock Price & Overview
NASDAQ:PRNB
Current stock price
The current stock price of PRNB is 100.05 null. Today PRNB is up by 0.1%. In the past month the price decreased by -0.81%. In the past year, price increased by 248.73%.
PRNB Key Statistics
- Market Cap
- 3.323B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.41
- Dividend Yield
- N/A
PRNB Stock Performance
PRNB Stock Chart
PRNB Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PRNB. When comparing the yearly performance of all stocks, PRNB is one of the better performing stocks in the market, outperforming 98.45% of all stocks.
PRNB Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PRNB. While PRNB has a great health rating, there are worries on its profitability.
PRNB Earnings
PRNB Forecast & Estimates
PRNB Financial Highlights
Over the last trailing twelve months PRNB reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -3112.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -137.82% | ||
| ROA | -17.85% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
PRNB Ownership
About PRNB
Company Profile
Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.
Company Info
Principia Biopharma Inc
220 East Grand Avenue
SOUTH SAN FRANCISCO CA 94080
CEO: Martin Babler
Phone: 650-416-7700
Principia Biopharma Inc / PRNB FAQ
What does Principia Biopharma Inc do?
Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.
What is the current price of PRNB stock?
The current stock price of PRNB is 100.05 null. The price increased by 0.1% in the last trading session.
Does PRNB stock pay dividends?
PRNB does not pay a dividend.
How is the ChartMill rating for Principia Biopharma Inc?
PRNB has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in Principia Biopharma Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRNB.